Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis [NA]

View source ↗

Summary

Clinical trial entry evaluating Huazhi Rougan Granule as add-on therapy for Helicobacter pylori infection with metabolic-associated steatohepatitis; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Huazhi Rougan Granule

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Helicobacter Pylori Infection, Metabolic-associated Steatohepatitis | NA | Status: NOT_YET_RECRUITING